Inspire Medical Systems, Inc. (INSP) Return on equity 2017–2025
Inspire Medical Systems, Inc. (INSP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
18.6%FY2025 · since FY2017: -1319.6% → 18.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 18.6% | +10.9 pp |
| FY2024 | 7.8% | +11.5 pp |
| FY2023 | -3.7% | +5.4 pp |
| FY2022 | -9.0% | +9.3 pp |
| FY2021 | -18.4% | +6.5 pp |
| FY2020 | -24.9% | -1.1 pp |
| FY2019 | -23.8% | -10.5 pp |
| FY2018 | -13.3% | +1306.3 pp |
| FY2017 | -1319.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More INSP financial trends
INSP RevenueINSP Net incomeINSP Net marginINSP Gross profitINSP Gross marginINSP Operating incomeINSP Operating marginINSP Operating cash flowINSP Free cash flowINSP Capital expendituresINSP Stock buybacksINSP Dividends paidINSP Total assetsINSP Total liabilitiesINSP Shareholders’ equityINSP overview →